<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Schultz KAP</submitter><funding>The Parson&amp;apos;s Foundation</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>521-527</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5716477</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>147(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Ovarian sex cord-stromal tumors (OSCST) include juvenile granulosa cell tumors (JGCT), Sertoli-Leydig cell tumor (SLCT) and gynandroblastoma (GAB) among others. These ovarian sex cord-stromal tumors as well as other tumors including pleuropulmonary blastoma (PPB) may be associated with DICER1 mutations. We sought to describe the clinical and genetic findings from the first 107 individuals enrolled in the International Ovarian and Testicular Stromal Tumor Registry.&lt;h4>Methods&lt;/h4>Medical and family history were obtained for individuals consecutively enrolled in the International Ovarian and Testicular Stromal Tumor Registry. Pathology was centrally reviewed. DICER1 sequencing was performed on blood and tumor tissue.&lt;h4>Results&lt;/h4>Of the 107 participants, 49 had SLCT, 25 </pubmed_abstract><journal>Gynecologic oncology</journal><pubmed_title>DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.</pubmed_title><pmcid>PMC5716477</pmcid><funding_grant_id>R01 CA143167</funding_grant_id><funding_grant_id>NCI R01CA143167</funding_grant_id><funding_grant_id>L40 CA171135</funding_grant_id><pubmed_authors>Finch M</pubmed_authors><pubmed_authors>Schneider DT</pubmed_authors><pubmed_authors>Hill DA</pubmed_authors><pubmed_authors>Stewart DR</pubmed_authors><pubmed_authors>Schultz KAP</pubmed_authors><pubmed_authors>Frazier AL</pubmed_authors><pubmed_authors>Dehner LP</pubmed_authors><pubmed_authors>Turner J</pubmed_authors><pubmed_authors>Gershenson DM</pubmed_authors><pubmed_authors>Messinger Y</pubmed_authors><pubmed_authors>Field A</pubmed_authors><pubmed_authors>Yu W</pubmed_authors><pubmed_authors>Cost NG</pubmed_authors><pubmed_authors>Harris AK</pubmed_authors><pubmed_authors>Young RH</pubmed_authors><pubmed_authors>Brown JB</pubmed_authors></additional><is_claimable>false</is_claimable><name>DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.</name><description>&lt;h4>Background&lt;/h4>Ovarian sex cord-stromal tumors (OSCST) include juvenile granulosa cell tumors (JGCT), Sertoli-Leydig cell tumor (SLCT) and gynandroblastoma (GAB) among others. These ovarian sex cord-stromal tumors as well as other tumors including pleuropulmonary blastoma (PPB) may be associated with DICER1 mutations. We sought to describe the clinical and genetic findings from the first 107 individuals enrolled in the International Ovarian and Testicular Stromal Tumor Registry.&lt;h4>Methods&lt;/h4>Medical and family history were obtained for individuals consecutively enrolled in the International Ovarian and Testicular Stromal Tumor Registry. Pathology was centrally reviewed. DICER1 sequencing was performed on blood and tumor tissue.&lt;h4>Results&lt;/h4>Of the 107 participants, 49 had SLCT, 25 </description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Dec</publication><modification>2026-05-05T20:56:09.464Z</modification><creation>2019-03-27T00:09:19Z</creation></dates><accession>S-EPMC5716477</accession><cross_references><pubmed>29037807</pubmed><doi>10.1016/j.ygyno.2017.09.034</doi></cross_references></HashMap>